Association of cannabis potency with mental ill health and addiction: a systematic review
Cannabis potency, defined as the concentration of Δ 9-tetrahydrocannabinol (THC), has
increased internationally, which could increase the risk of adverse health outcomes for …
increased internationally, which could increase the risk of adverse health outcomes for …
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2024
Diabetes Care, 2024 - Am Diabetes Assoc
The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …
ADA's current clinical practice recommendations and is intended to provide the components …
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD: THC ratios
As countries adopt more permissive cannabis policies, it is increasingly important to identify
strategies that can reduce the harmful effects of cannabis use. This study aimed to determine …
strategies that can reduce the harmful effects of cannabis use. This study aimed to determine …
Cannabis-related disorders and toxic effects
DA Gorelick - New England Journal of Medicine, 2023 - Mass Medical Soc
Cannabis-Related Disorders and Toxic Effects | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …
content The New England Journal of Medicine homepage Advanced Search SEARCH …
Prevalence of adolescent cannabis vaping: a systematic review and meta-analysis of US and Canadian studies
Importance Vaping products were initially designed to deliver nicotine as a tobacco cigarette
substitute (eg, electronic cigarettes) but are now frequently used to deliver psychoactive …
substitute (eg, electronic cigarettes) but are now frequently used to deliver psychoactive …
Trends in the use of cannabis products in Canada and the USA, 2018–2020: Findings from the International Cannabis Policy Study
Abstract Background and Aims There is little information on consumption patterns across the
diverse range of cannabis product types. This paper examines trends in consumption …
diverse range of cannabis product types. This paper examines trends in consumption …
The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use
Background The lack of an agreed international minimum approach to measuring cannabis
use hinders the integration of multidisciplinary evidence on the psychosocial …
use hinders the integration of multidisciplinary evidence on the psychosocial …
[HTML][HTML] Cannabinoids and the endocannabinoid system in fibromyalgia: A review of preclinical and clinical research
Characterised by chronic widespread musculoskeletal pain, generalised hyperalgesia, and
psychological distress, fibromyalgia (FM) is a significant unmet clinical need. The …
psychological distress, fibromyalgia (FM) is a significant unmet clinical need. The …
Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates
Background Cannabis is one of the most widely used substances worldwide. Heavy use is
associated with an increased risk of cannabis use disorders, psychotic disorders, acute …
associated with an increased risk of cannabis use disorders, psychotic disorders, acute …
Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis
Cannabis, a widely used psychoactive substance, can trigger acute cannabis-associated
psychotic symptoms (CAPS) in people who use cannabis (PWUC). To assess rates and …
psychotic symptoms (CAPS) in people who use cannabis (PWUC). To assess rates and …